好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

OnabotulinumtoxinA for Treatment of Chronic Migraine: 56-Week Analysis of the PREEMPT Chronic Migraine Subgroup with Baseline Acute Headache Medication Overuse
Headache
(-)
005
Authors/Disclosures
Stephen D. Silberstein, MD, FAAN (Jefferson Headache Center) Dr. Silberstein has received publishing royalties from a publication relating to health care.
Joel R. Saper, MD, FAAN (MHNI) No disclosure on file
Michael R. Stein, MD No disclosure on file
No disclosure on file
Catherine C. Turkel, Pharm (Allergan, Inc.) No disclosure on file
Pauline Maki, PhD (Center for Cognitive Med/Dept of Psychiatry) No disclosure on file
No disclosure on file